RecruitingNot Applicable

Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea

South Korea2,000 participantsStarted 2003-07-01

Plain-language summary

To assess antimicrobial resistance rates and minimal inhibitory concentrations in H. pylori isolated from patients with upper gastrointestinal disease with long-term period.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects who had a H. pylori infection and had consented to undergo culture analysis via endoscopic resection, in order to determine the minimal inhibitory concentration (MIC) of various antibiotics. Exclusion Criteria: * Patients with a concurrent critical illness, who abused drugs or alcohol, who were pregnant or nursing, or those who had received antibiotics, PPIs, or bismuth salts within 4 weeks, were excluded.

What they're measuring

Resistance rate

Timeframe: through study completion, an average of 1 year

Minimal inhibitory concentration (MIC) distribution

Timeframe: through study completion, an average of 1 year

Multiple resistance, prevalance and trends

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT05247112

SponsorSeoul National University Bundang Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-12-31

Contact for this trial

Jung Won Lee, M.D.

+ 82-10-9356-7758 saludos@naver.com

View on ClinicalTrials.gov More Helicobacter Pylori Infection trials